Vivani Medical
VANI
28 hedge funds and large institutions have $10M invested in Vivani Medical in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 9 closing their positions.
1,780% more call options, than puts
Call options by funds: $188K | Put options by funds: $10K
138% more capital invested
Capital invested by funds: $4.22M → $10M (+$5.83M)
31.78% more ownership
Funds ownership: 1.76% → 33.54% (+32%)
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
0% more funds holding
Funds holding: 28 → 28 (0)
67% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TWM
Tanager Wealth Management
Goring On Thames,
United Kingdom
|
+$12.5M |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$1.71M |
| 3 |
MMG
Monetary Management Group
St Louis,
Missouri
|
+$1.53M |
| 4 |
BlackRock
New York
|
+$1.39M |
| 5 |
GWS
Glassman Wealth Services
Vienna,
Virginia
|
+$666K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$337K |
| 2 |
HF
HRT Financial
New York
|
-$123K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$105K |
| 4 |
Millennium Management
New York
|
-$66.7K |
| 5 |
VF
Virtu Financial
New York
|
-$63K |
VANI Hedge Fund Activity: Q3 2022 in Review
28 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2022, worth a combined $10M — up 138% from $4.22M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new VANI positions and 9 closed out — a net gain of 1 holder — while 4 added to existing stakes and 12 trimmed.
The largest buyer was Tanager Wealth Management, opening a new position worth an estimated $12.5M. The largest seller was Morgan Stanley, cutting an estimated $337K.
- 28 institutional investors held Vivani Medical (VANI) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $10M of Vivani Medical stock for Q3 2022, up 138% quarter-over-quarter.
- 10 funds opened new Vivani Medical positions in Q3 2022 and 9 closed out, a net change of +1 holder.
- The largest Vivani Medical buyer in Q3 2022 was Tanager Wealth Management, an estimated $12.5M added.
- The largest Vivani Medical seller in Q3 2022 was Morgan Stanley, an estimated $337K sold.
Based on aggregated 13F filings for Q3 2022.